Donald Trump was not the only big winner on Election Day. The cannabis industry got a spark as well with California, Nevada and a handful of other states legalizing recreational marijuana use. "It's only getting started," Timothy Taggart, portfolio manager for the American Growth Fund Series Two Fund. "The cannabis industry is going to go from $2 billion a year to $20 billion by 2010." One of Taggart's top picks in this new era of pot politics is the Scotts Miracle-Gro Company (SMG) , up 36% year-to-date. Insys Therapeutics (INSY) , down 53% year-to-date, is another one of Taggart's favorite marijuana-related stocks. Finally, Taggart is a fan of Cannabis Sativa (CBDS) , which makes skin-care and other products based from cannabis, that has seen its stock spike from $0.70 a share in January to more than $5.50 at last check.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.